The present invention relates to a stable pharmaceutical composition comprising tigecycline and arginine, to a process for the manufacture of said pharmaceutical composition as well as to the its use in the treatment of bacterial infections.La présente invention concerne une composition pharmaceutique stable comprenant de la tigécycline et de l'arginine, un procédé de préparation de ladite composition pharmaceutique et son utilisation dans le traitement d'infections bactériennes.
